
ASCO® 2023
Dana-Farber Cancer Institute
ASCO® 2023 Summary: "RCC Updates From The Recent Trials"
FEATURING
Wenxin Xu,
Toni Choueiri
- 242 views
- July 21, 2023
Dana-Farber Cancer Institute
ASCO® 2023 Summary: "Prostate Cancer Updates From The Recent Trials"
FEATURING
Jacob Berchuck,
Mary-Ellen Taplin
- 186 views
- July 21, 2023
Dana-Farber Cancer Institute
ASCO® 2023 Summary: "Bladder Cancer Updates From The Recent Trials"
FEATURING
Charlene Mantia,
Joaquim Bellmunt
- 118 views
- July 21, 2023
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Optimizing Therapy Selection for Patients With Renal Cell Carcinoma"
FEATURING
Bradley McGregor
- 454 views
- June 22, 2023
- 3
Dana-Farber Cancer Institute
ASCO® 2023 Insights: "Initial Chemo for Locally Advanced & Metastatic NUT Carcinoma"
FEATURING
Jia Luo
- 59 views
- June 14, 2023
Dana-Farber Cancer Institute
ASCO® 2023 Insights: "Prognosis & Trends in Adjuvant Chemo Use for Pts With Stage IA TNBC"
FEATURING
Paolo Tarantino
- 92 views
- June 14, 2023
- 1
Dana-Farber Cancer Institute
ASCO® 2023 Insights: "TROPiCS-02 Final OS Analysis of Sacituzumab Govitecan in Pts With HR+/HER2- mBC"
FEATURING
Sara Tolaney
- 175 views
- June 14, 2023
- 1